August 9, 2025

The effects of Honokiol on the liver of Alzheimer's disease mice by upregulating SIRT3.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Research reveals honokiol improves liver function and reduces Aβ1-42 plaque in Alzheimer’s mice, indicating hepatic pathways in treatment efficacy.

Honokiol significantly reduces Aβ1-42 plaque deposition in the brains of Alzheimer's disease mice.
Hepatic morphology improves, evidenced by increased levels of liver function markers following honokiol treatment.
SIRT3 expression is enhanced, with honokiol elevating both SIRT3 mRNA and protein levels in the liver tissue.
These findings suggest honokiol's potential to mitigate liver damage through SIRT3 activation in Alzheimer’s disease.

Wang et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research reveals honokiol improves liver function and reduces Aβ1-42 plaque in Alzheimer’s mice, indicating hepatic pathways in treatment efficacy.